ACE Report Cover
Despite initial migration, Furlong Active stem comparable to Furlong HAC after 5 years
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Lingua
Download Download Download
Scaricare
Cite this Report Cite this Report Cite this Report
Citare
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Preferiti
OSTEOARTHRITIS
Despite initial migration, Furlong Active stem comparable to Furlong HAC after 5 years .

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2015;3(6):29 Acta Orthop. 2014 Dec;85(6):556-61.
Autori che hanno contribuito

E Weber M Sundberg G Flivik

50 patients with primary osteoarthritis undergoing total hip arthroplasty were randomized to receive either the Furlong Active femoral stem or the traditional Furlong HAC femoral stem. The purpose of this study was to evaluate the 3-D migratory patterns of the two stems using radiostereometry. Results after 3 months demonstrated significantly greater subsidence of the Furlong Active stem compared to the Furlong HAC stem, though subsidence of each stem plateaued after 3 months and displayed minor changes through to 5 years. Both groups displayed initial retroversion of the implant at 3 months, though minimal differences through to 5 years thereafter. Clinical outcome significantly improved in both groups over 5 years, with no significant differences detected between groups at 1, 2, or 5 year follow-up.


Dettagli sul finanziamento della pubblicazione +
Finanziamento:
Industry funded
Sponsor:
JRI Ltd.
Conflitti:
None disclosed

Rischio di pregiudizio

6,5/10

Criteri di segnalazione

14/20

Indice di fragilità

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Sì = 1

Incerto = 0,5

Non rilevante = 0

No = 0

La valutazione dei criteri di segnalazione valuta la trasparenza con cui gli autori riportano le caratteristiche metodologiche e sperimentali dello studio all'interno della pubblicazione. La valutazione è suddivisa in cinque categorie che vengono presentate di seguito.

1/4

Randomization

2/4

Outcome Measurements

4/4

Inclusion / Exclusion

4/4

Therapy Description

3/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

L'Indice di Fragilità è uno strumento che aiuta l'interpretazione dei risultati significativi, fornendo una misura della forza di un risultato. L'Indice di Fragilità rappresenta il numero di eventi consecutivi che devono essere aggiunti a un risultato dicotomico per rendere il risultato non più significativo. Un numero piccolo rappresenta un risultato più debole, mentre un numero grande rappresenta un risultato più forte.

Perché questo studio era necessario ora?

The Furlong HAC stem is a well-proven femoral implant that has recently undergone modifications to the lateral fin to prevent fracture of the greater trochanter during insertion. The new stem - the Furlong Active stem - is a shorter cone-shape, double-tapered, and has more rounded medial and lateral edges. Using radiostereometry, this study aimed to compare the migratory patterns of the Furlong HAC and Furlong Active stem as a surrogate for osseointegration and long-term survival of the arthroplasty.

Qual era la domanda di ricerca principale?

Do design modifications to the Furlong HAC stem to give the Furlong Active stem affect the migratory behaviour, osseointegration and long-term result of total hip arthroplasty up to 5 years after surgery?

Caratteristiche dello studio +
Population:
50 patients (mean age: 63 years, mean BMI: 27, 27M/23F) with primary osteoarthritis scheduled for total hip arthroplasty. Patients who had unstable femoral anatomy as determined by radiographs and who were Charnley category C patients were excluded from the study. 45 patients (23M/20F) completed the study to completion at the 5 year endpoint. Surgery for both groups was performed using a posterolateral approach and 8-10 tantalum bone markers (diameter=0.8 mm). Apart from the femoral head used as a marker, all prostheses were pre-marked with tantalum markers at the tip, shoulder and medial collar of the stem.
Intervention:
Furlong Active group: Participants received the Furlong Active stem. Material was titanium alloy with a hydroxyapatite coating for uncemented implantation (n=25; 9M/16F) (Mean age: 62 years, range: 50-77 years)
Comparison:
Furlong HAC group: Participants received the Furlong HAC stem. Material was titanium alloy with a hydroxyapatite coating for uncemented implantation (n=25; 18M/7F) (Mean age: 63 years, range: 49-75 years)
Outcomes:
Radiostereometry (RSA) and conventional radiographic examinations were performed to analyze motion of the stem in relation to the tantalum markers implanted in the femur. Stem subsidence (Y-translation) and retroversion (Y-rotation) were primary effect variables. Self-administered Hip Disability and Osteoarthritis Outcome Score (HOOS) was also assessed.
Methods:
RCT: Single-centre
Time:
Radiostereometry (RSA) and conventional radiographic examinations were conducted on the first postoperative day, before weight-bearing and then at 3 months, 1,2 and 5 years (+/-5% time tolerance) postoperatively. Routine clinical follow-up occurred 3 months and 1, 2 and 5 months postoperatively. Hip Disability and Osteoarthritis Outcome Score was evaluated prior to surgery and at 1, 2 and 5 years.
Quali erano i risultati importanti?
  • Significantly greater subsidence of the implant was noted in the Furlong Active group (0.99mm distally) compared to the Furlong HAC group (0.31mm distally) (p=0.0.46). Subsequent subsidence from 3 months to 5 years was not statistically significant in the Furlong Active (p=0.5) or HAC (p=0.06) stem.
  • There was one case of extreme subsidence reported in the Furlong Active group (6.5mm after 3 months) in a patient with BMI 41. Exclusion of this outlier case from the main analysis resulted in a non-significant difference in subsidence between groups (p>0.05).
  • Mean retroversion of the femoral stem was measured at 1.18deg in the Furlong Active group and 0.80deg in the Furlong HAC group after 3 months; the difference between groups was not statistically significant. (p=0.46). From 3 month to 5 years, no significant changes in mean retroversion were noted in either the Furlong Active (p=0.1) or HAC group (p=0.1).
  • Two patients, one in the Furlong HAC group (4.2 degrees) and one in the Furlong Active group (5.1 degree), demonstrated significant retroversion of the stem within the first 3 months after surgery. Between 3 months and 5 years, no further retroversion was noted in either patient.
  • No stem in either group was judged to be loose over the 5 year follow-up period.
  • HOOS scores improved significantly within both groups, without significant difference between groups at 1, 2, or 5 years after surgery.
  • Minor X- and Z-plane translation and rotation of the stem were noted in both groups, and differences were small between groups.
Che cosa devo ricordare di più?

In total hip arthroplasty, subsidence of the uncemented Furlong Active femoral stem was significantly greater than the Furlong HAC stem in the first 3 months after surgery, although subsidence in both groups thereafter plateaued, with minimal subsidence occurring in either group from 3 months to 5 years. Both stems displayed initial retroversion of the femoral implant in the first 3 months, but minor changes thereafter to 5 years. No stem in either group was considered loose. Clinical outcome was similar between the Furlong Active and HAC stem throughout the 5-year follow-up.

Come influenzerà l'assistenza ai miei pazienti?

Though subsidence of the Furlong Active stem was greater than that of the Furlong HAC stem, early migration did not appear to negatively impact 5-year outcome. Namely, osseointegration of the implant was observed to occur after 3 months, with minimal subsidence migration of either implant from 3 month to 5 years, and no loose components observed. Additionally, retroversion did not appear to substantial differ between stem designs. These findings suggest that similar results may be attained with the new Furlong Active stem relative the standard Furlong HAC stem, and that the new design modifications do not negatively affect integration of the component or clinical results. Nevertheless, additional research in a larger cohort of trials should be considered to confirm the the findings of the current study.

DISCLAIMER

Il contenuto di questa pagina è solo a scopo informativo e non intende sostituire la consulenza, la diagnosi o il trattamento medico professionale. Se ha bisogno di cure mediche, si rivolga sempre al suo medico o al pronto soccorso più vicino. Le opinioni, le convinzioni e i punti di vista espressi dalle persone sui contenuti presenti in questa pagina non riflettono le opinioni, le convinzioni e i punti di vista di OrthoEvidence.

0 di 4 articoli mensili GRATUITI sbloccati
Ha raggiunto il suo limite di 4 visualizzazioni di articoli gratuiti questo mese

Accesso a OrthoEvidence a soli 1,99 dollari a settimana.

Rimanga in contatto con le ultime prove. Può disdire in qualsiasi momento.
  • Valutazioni critiche dei più recenti studi randomizzati controllati ad alto impatto e delle revisioni sistematiche in ortopedia.
  • Accesso ai contenuti del podcast OrthoEvidence, tra cui collaborazioni con il Journal of Bone and Joint Surgery, interviste con chirurghi di fama internazionale e tavole rotonde su notizie e argomenti ortopedici.
  • Abbonamento a The Pulse, una newsletter bisettimanale basata sulle evidenze scientifiche, progettata per aiutarla a prendere decisioni cliniche migliori.
Upgrade
Close Dialog
Bentornato!
Ha dimenticato la password?
Inizi la sua prova gratuita oggi stesso!

Il suo account sarà affiliato a
e includerà l'accesso gratuito a OrthoEvidence


O
Ha dimenticato la password?

O
Controlli la sua e-mail

Se esiste un account con l'indirizzo e-mail fornito, le verrà inviata un'e-mail di reimpostazione della password. Se non vede l'e-mail, controlli la cartella spam o posta indesiderata.

Per ulteriore assistenza, contatti il nostro team di supporto.

Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Tradurre il Rapporto ACE

OrthoEvidence utilizza un servizio di traduzione di terze parti per rendere i contenuti accessibili in più lingue. Si prega di notare che, sebbene venga fatto ogni sforzo per garantire l'accuratezza, le traduzioni potrebbero non essere sempre perfette.

Come citare questo documento ACE Report

OrthoEvidence. Despite initial migration, Furlong Active stem comparable to Furlong HAC after 5 years. OE Journal. 2015;3(6):29. Available from: https://myorthoevidence.com/AceReport/Show/despite-initial-migration-furlong-active-stem-comparable-to-furlong-hac-after-5-years

Copiare la citazione
Effettui il login per abilitare questa funzione

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence attivo. Effettui il login o crei un account di prova GRATUITO.

Funzionalità per i membri Premium

Per accedere a questa funzione, deve essere collegato ad un account OrthoEvidence Premium.

Condividi questo articolo ACE Report